2579P Development of a patient-reported outcome measure for individuals at risk for hereditary cancer: Phase I - IIIa of the EORTC QLQ-HCR30. - Engele, V.I.; Vasiliou, V.; Wheelwright, S.; Sztankay, M.; Puglisi, C.; Pogoda, K.; van Leeuwaarde, R.; Bleiker, E.; Abdel-Razeq, H.; Fox, L.; Lanceley, A.; Dabakuyo-Yonli, S.; et al. (Annals of Oncology, 2025)